EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Animal models of Huntington’s disease and their applicability to novel drug discovery and development

Shubham Upadhayay, Sumit Jamwal, Puneet Kumar

Expert Opinion on Drug Discovery · 04.05.2023 · 18 (5) · 527-538

DOI: 10.1080/17460441.2023.2201493 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Opinion on Drug Discovery, online erschienen am 11.04.2023. Verfasst von Shubham Upadhayay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Central University of Punjab, Bathinda, India. Hauptthemen laut MEDLINE: Huntington Disease. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 104 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Huntington's disease (HD) is a progressive neurodegenerative disorder caused by an expansion in the CAG trinucleotide repeat in huntingtin (Htt) gene. The discovery of the HD-causing gene prompted the creation of new HD animal models, proving that mutations in the HD gene are linked to either loss of function of the wild-type (un-mutated) gene or toxic gain in the function of a mutated gene. AREAS COVERED: Animal models of HD have led to an increased understanding of its pathogenesis and resulted in the discovery of new therapeutic targets/drugs. The focus of this review is on the selection and validation of animal models for HD drug discovery. Furthermore, several drugs tested using various models in the preclinical phase have been compiled to demonstrate the applicability of these HD animal models. EXPERT OPINION: The applicability of animal models for HD drug discovery has been well demonstrated. Nevertheless, despite the enormous progression made to date, the development of drug therapy to completely alleviate disease progression has not been achieved. Most of the pre-clinically tested drugs have shown promising results in alleviating HD-associated neurodegeneration and motor and non-motor symptoms, but only a few of them thrived to produce satisfactory results in the clinical phase. This failure has raised concerns about the selection of HD animal models and species, and new strategies for selection are mandated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseAnimalsDisease Models, Animal

Stichwörter der Autor:innen

Huntington’s diseaseanimal modelsdrug developmentdrug discoveryneurodegeneration

Autor:innen und Institutionen

  • Department of Pharmacology, Central University of Punjab, Bathinda, India.
  • Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

Zitieren

APA

Upadhayay, S., Jamwal, S., & Kumar, P. (2023). Animal models of Huntington’s disease and their applicability to novel drug discovery and development. Expert Opinion on Drug Discovery, 18(5), 527-538. https://doi.org/10.1080/17460441.2023.2201493

Vancouver

Upadhayay S, Jamwal S, Kumar P. Animal models of Huntington’s disease and their applicability to novel drug discovery and development. Expert Opinion on Drug Discovery. 2023;18(5):527-538. doi:10.1080/17460441.2023.2201493

BibTeX
@article{Upadhayay2023,
  author = {Upadhayay, Shubham and Jamwal, Sumit and Kumar, Puneet},
  title = {Animal models of Huntington’s disease and their applicability to novel drug discovery and development},
  journal = {Expert Opinion on Drug Discovery},
  year = {2023},
  volume = {18},
  number = {5},
  pages = {527--538},
  doi = {10.1080/17460441.2023.2201493}
}
Kostenlos starten →